Across TCGA pan-cancer cohorts, MIR514A1 RNA is linked to patient survival in 3 of 34 cancer types, making it the most broadly survival-associated MIR514A1 data layer compared with 1 for mutation status.

The strongest signal is observed in rectum adenocarcinoma (READ), where higher MIR514A1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR514A1 expression acts as an unfavorable survival marker, although some lineages such as KIRC show a favorable association.

READ, KIRC, and STAD are the cancer types where MIR514A1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
READ	OS	Tertile	II,III,IV	0.111	0.919	<.001	135	view →
KIRC	OS	Tertile	All	0.937	0.858	.003	126	view →
STAD	DFS	Tertile	All	0.193	0.587	.025	9	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: MIR514A1 tumor-vs-normal RNA expression · all MIR514A1 data types